Video

Safety Profile of S1P Receptor Modulators for Multiple Sclerosis

Krzysztof Selmaj, MD, PhD, discusses the side effects of sphinogine-1-phospate (S1P) receptor modulators, highlighting particular adverse events clinicians should be aware of when treating multiple sclerosis (MS).

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Videos
 Sumaira Ahmed
Tiffany Malone, MSW, MSCS
Ahmed Abdelhak, MD
Smathorn Thakolwiboon, MD
Gabrielle Macaron, MD
© 2025 MJH Life Sciences

All rights reserved.